[8-K] Doximity, Inc. Reports Material Event

Rhea-AI Filing Summary

Analyzing...

Insights

Financial Analyst

TL;DR: Major insider sale—78.7k shares sold; stake cut to 9k; signals reduced personal exposure.

The magnitude and timing of the sales—≈$23 m in two days—indicate deliberate diversification rather than routine liquidity. Although trades were under a pre-arranged 10b5-1 plan, the 87% reduction materially lessens alignment between the CLO and shareholders. The near-market-high prices ($294-$298) suggest opportunistic execution. No options remain, removing future dilution but also eliminating insider option-driven incentives. Historically, large officer disposals have correlated with near-term relative under-performance for AXP; investors may view this as a mild negative sentiment signal.

Corporate Governance Expert

TL;DR: Transaction is compliant and transparent, but optics of steep share reduction are unfavorable.

Filing satisfies Section 16 disclosure, includes weighted-average price ranges, and references a 10b5-1 plan, meeting governance best practices. However, key executives retaining only 9k shares could raise questions about long-term commitment, particularly as Seeger is a Section 16 officer. Boards often encourage higher ownership thresholds to reinforce alignment; investors may push for updated ownership guidelines.

0001516513FALSE00015165132025-08-062025-08-06

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

_________________________________________________________________________________________________________________

FORM 8-K

_________________________________________________________________________________________________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 7, 2025

_________________________________________________________________________________________________________________

Doximity, Inc.

(Exact Name of Registrant as Specified in Its Charter)

_________________________________________________________________________________________________________________

Delaware			001-40508			27-2485512
(State or Other Jurisdiction of Incorporation)			(Commission File Number)			(I.R.S. Employer Identification Number)
500 3rd St. Suite 510 San Francisco, CA 94107 (Address of principal executive offices, including zip code)
(650) 549-4330 (Registrant's telephone number, including area code)

_______________________________________________________________________________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Class A common stock, $0.001 par value per share

DOCS

The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 – Results of Operations and Financial Condition

On August 7, 2025, Doximity, Inc. (“Doximity”) issued a press release announcing its financial results for its fiscal quarter ended June 30, 2025. A copy of the press release is attached as Exhibit 99.1 to this current report on Form 8-K and is incorporated by reference herein.

The information provided in this Item 2.02 of this Current Report on Form 8-K, and the Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 – Financial Statements and Exhibits

(d) Exhibits

Exhibit Number						Description
99.1						Press Release entitled “Doximity Announces Fiscal 2026 First Quarter Financial Results dated August 7, 2025”
104						Cover Page Interactive Data File (embedded within the inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: August 7, 2025

			DOXIMITY, INC.
			By:			/s/ Anna Bryson
						Anna Bryson Chief Financial Officer